Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Canagliflozin in Type 2 Diabetes With Diabetic Nephropathy (China Substudy of CREDENCE-like Trial)
CTR20150744Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of canagliflozin in type 2 diabetes mellitus (T2DM), diabetic glomerulosclerosis, sponsored by Janssen Pharmaceutical. Started Nov 2015; status: completed.
02
Drugs
canagliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)diabetic glomerulosclerosis
Beyond the preview
Go deeper on CTR20150744.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150744.